skip to Main Content

AIM-HI Women's Venture Competition
Thursday, September 24, 2020

The AIM-HI Accelerator Fund congratulates our 8 women scientist-entrepreneur semi-finalists and their companies of our inaugural Women’s Venture Competition on Thursday, September 24th. We will be announcing the two finalists of the competition. The winning business will receive an equity investment of $300,000 by AIM-HI, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

In addition to announcing the top two finalists from our pool of 8 semi-finalists, the AIM-HI Women’s Venture Competition is looking to name one of our semi-finalists as the People’s Choice Award for Best Pitch. Who will it be? We can’t all be on the official Judging Committee for the Women’s Venture Competition …  but we can ALL Cast our Vote! 

Ready to do more? DONATE NOW and help us double the impact for women scientist-entrepreneurs who are creating life-saving oncology innovations!

Semi-Finalists

Stacy Blain, Ph.D.
Founder & CSO

Concarlo Holdings

Maryam Ziaei, Ph.D.
CEO

iSonoHealth

Yue Meng, Ph.D.
Co-Founder

Kancure Therapeutics

María José Alonso, Ph.D.
Founder & CSO

Libera Bio

Laura Towart
Founder & CEO

My Personal Therapeutics

Margaret Offermann, M.D., Ph.D.
CEO

OncoSpherix

Manijeh Goldberg, Ph.D.
CEO

Privo Technologies

Cindy Clark, J.D.
CEO & President

RecurX Bio
Back To Top